In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of tamping down prescription drug costs. The new law targets pharmacy benefit ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts, and Indiana’s ...
Tampa Free Press on MSN9h
Biden-Harris FTC Takes Legal Action Over Insulin Price InflationFriday initiated legal action against the three largest prescription drug benefit managers (PBMs) in the U.S.—Caremark Rx, ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
PBMs, like Optum Rx, are the key counterweight to pharmaceutical companies’ otherwise unchecked monopoly power to set and raise drug prices.
The FTC accuses the largest pharmacy benefit manager companies of unfairly boosting prices on prescription drugs.
The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback